Aim & Scope
Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline. In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals. [1]
Continuations / Journal History
| ( 2004 - 2009 ) | Nature Clinical Practice - Oncology | ( 2009 - 9999 ) | Nature Reviews - Clinical Oncology |
Series / Collection
2731-6092 ( Online )
Nature Research
,
Springer
1474-175X ( Print )
1474-1768 ( Online )
Nature Research
,
Springer
1759-5002 ( Print )
1759-5010 ( Online )
Nature Research
,
Springer
2397-3358 ( Online )
Nature Research
,
Springer
Nature Reviews - Clinical Oncology
1759-4774 ( Print )
1759-4782 ( Online )
Nature Research
,
Springer
2056-676X ( Online )
Nature Research
,
Springer
1474-1776 ( Print )
1474-1784 ( Online )
Nature Research
,
Springer
2662-138X ( Online )
Nature Research
,
Springer
2948-1201 ( Online )
Nature Research
,
Springer
1759-5029 ( Print )
1759-5037 ( Online )
Nature Research
,
Springer
2024
Spatial landscapes of cancers: insights and opportunities.
J Chen , L Larsson , A Swarbrick , J Lundeberg
Nature Reviews - Clinical Oncology , 2024
BrECADD raises the bar in classical Hodgkin lymphoma
Nature Reviews - Clinical Oncology , 2024
HER2-targeted therapies beyond breast cancer — an update
Nature Reviews - Clinical Oncology , 2024
Tisotumab vedotin effective in recurrent cervical cancer
Nature Reviews - Clinical Oncology , 2024
BCMA-directed therapy for early relapsed and/or refractory multiple myeloma
Nature Reviews - Clinical Oncology , 2024
Targeting chromosomal instability in patients with cancer
DH Al-Rawi , E Lettera , J Li , ... , SF Bakhoum
Nature Reviews - Clinical Oncology , 2024
Vimseltinib improves outcomes in tenosynovial giant cell tumour
Nature Reviews - Clinical Oncology , 2024
Promising outcomes with liso-cel in patients with R/R follicular lymphoma.
Nature Reviews - Clinical Oncology , 2024
Editorial Retractions, Expressions of Concern and External Notices
Genetics: Are circRNAs involved in cancer pathogenesis?
Nature Reviews - Clinical Oncology2016 - VOLUME 13, ISSUE 11 p 658.
12 10
Nature Reviews - Clinical Oncology
2016 - VOLUME 13, ISSUE 11
2 1
PubPeer
2016 - VOLUME 2016, ISSUE 10
0 0
